Lori J. Braender

Overview

Lori J. Braender received an average of $1M in total compensation, including $415K in salary, at Aquestive Therapeutics between 2022 and 2023.

Source: SEC filing on April 26, 2024.

Related executives

We found four more executives who work or worked at Aquestive Therapeutics.

Daniel Barber

Aquestive Therapeutics

Chief Executive Officer

A Toth

Aquestive Therapeutics

Chief Financial Officer

Keith Kendall

Aquestive Therapeutics

Chief Executive Officer

John Maxwell

Aquestive Therapeutics

Chief Financial Officer

News

You may also like